Teleflex (NYSE:TFX) Stock Price Down 5.5% – What’s Next?

Posted by Brian Himes on Jul 16th, 2026

Shares of Teleflex Incorporated (NYSE:TFX – Get Free Report) dropped 5.5% during trading on Tuesday . The company traded as low as $128.96 and last traded at $128.9490. Approximately 64,352 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 832,030 shares. The stock had previously closed at $136.40.

Wall Street Analyst Weigh In

TFX has been the topic of several research reports. Bank of America raised Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a research note on Monday, April 13th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and upped their price objective for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Raymond James Financial restated an “outperform” rating and set a $150.00 target price on shares of Teleflex in a report on Friday, May 8th. BMO Capital Markets initiated coverage on shares of Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective on the stock. Finally, Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $148.00.

Check Out Our Latest Analysis on TFX

Teleflex Price Performance

The stock has a market cap of $5.84 billion, a P/E ratio of -5.79, a P/E/G ratio of 0.97 and a beta of 0.82. The company’s 50 day moving average price is $130.38 and its 200-day moving average price is $120.30. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. The business had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.Teleflex’s quarterly revenue was up 32.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, sell-side analysts expect that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, May 22nd. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Institutional Investors Weigh In On Teleflex

Large investors have recently modified their holdings of the company. AQR Capital Management LLC increased its stake in shares of Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after acquiring an additional 1,956,811 shares in the last quarter. Irenic Capital Management LP purchased a new stake in Teleflex in the 1st quarter valued at $104,061,000. Norges Bank purchased a new position in Teleflex during the fourth quarter worth about $66,076,000. Wolf Hill Capital Management LP purchased a new stake in shares of Teleflex during the fourth quarter valued at approximately $47,405,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of Teleflex by 123.9% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company’s stock worth $80,855,000 after purchasing an additional 365,663 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

About Teleflex

(Get Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.